Opioid substitution to improve the effectiveness of chronic noncancer pain control: A chart review

被引:89
作者
Do Quang-Cantagrel, N [1 ]
Wallace, MS [1 ]
Magnuson, SK [1 ]
机构
[1] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA
关键词
D O I
10.1213/00000539-200004000-00029
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We evaluated the efficacy and tolerability of opioids in the long-term management of chronic noncancer pain. This retrospective chart review included 86 outpatients who started receiving, between 1994 and 1998, long-acting opioids. For each patient, the number of different opioids used and the efficacy and tolerability of each opioid prescribed were noted. During a mean follow-up of 8.8 +/- 6.3 mo, the number of opioids used by each patient was 2.3 +/- 1.4. Patient diagnoses were: back pain (31), neuropathy (20), joint pain (13), visceral pain (7), reflex sympathetic dystrophy (7), headache (5), fibromyalgia (3). The first opioid prescribed was effective for 36% of patients, was stopped because of side effects in 30%, and was stopped for ineffectiveness in 34%. Of the remaining patients, the second opioid prescribed after the failure of the first was effective in 31%, the third in 40%, the fourth in 56%, and the fifth in 14%. There was one case of addiction and no case of tolerance. We conclude that if it is necessary to change the opioid prescription because of intolerable side effects or ineffectiveness, the cumulative percentage of efficacy increases with each new opioid tested. Failure of one opioid cannot predict the patient's response to another. Implications: This study showed that if a patient receiving chronic opioid therapy experiences an intolerable side effect or if the drug is ineffective, changing to a different opioid may result in a lessening or elimination of the side effect and/or improved analgesia.
引用
收藏
页码:933 / 937
页数:5
相关论文
共 26 条
[1]  
Bouckoms A, 1992, ANN CLIN PSYCHIAT, V4, P185
[2]   Opioid analgesics - Comparative features and prescribing guidelines [J].
Cherny, NI .
DRUGS, 1996, 51 (05) :713-737
[3]  
CHERNY NI, 1993, CANCER-AM CANCER SOC, V72, P3393, DOI 10.1002/1097-0142(19931201)72:11+<3393::AID-CNCR2820721606>3.0.CO
[4]  
2-O
[5]   Morphine metabolites [J].
Christrup, LL .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1997, 41 (01) :116-122
[6]  
CREWS JC, 1993, CANCER-AM CANCER SOC, V72, P2266, DOI 10.1002/1097-0142(19931001)72:7<2266::AID-CNCR2820720734>3.0.CO
[7]  
2-P
[8]  
DICKENSON AH, 1994, CANCER SURV, V21, P5
[9]   INDIVIDUAL VARIABILITY IN THE RESPONSE TO DIFFERENT OPIOIDS - REPORT OF 5 CASES [J].
GALER, BS ;
COYLE, N ;
PASTERNAK, GW ;
PORTENOY, RK .
PAIN, 1992, 49 (01) :87-91
[10]   A COMPARATIVE-STUDY OF THE EFFICACY AND PHARMACOKINETICS OF ORAL METHADONE AND MORPHINE IN THE TREATMENT OF SEVERE PAIN IN PATIENTS WITH CANCER [J].
GOURLAY, GK ;
CHERRY, DA ;
COUSINS, MJ .
PAIN, 1986, 25 (03) :297-312